May 20 (Reuters) - Pfizer said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune ...
Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued US Stocks According to Hedge Funds. On May 13, Pfizer Inc.
Zacks Investment Research on MSN
Is trending stock Pfizer Inc. (PFE) a buy now?
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
LOE risks are mitigated by delayed Vyndamax generic entry to mid-2031, supporting the management’s high single-digit 5Y ...
PFE bets on Padcev, biosimilars and late-stage pipeline candidates to drive long-term oncology growth amid pressure on legacy ...
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
The registrar ultimately concluded that the competing trademarks were “overall, dissimilar”. Read more at straitstimes.com.
The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing time and ...
Pfizer (PFE +0.85%) stock reached all-time highs earlier this decade thanks to the company's dominance in the market for ...
In my March article, "Why Pfizer Remains A Strong Buy In 2026", I mainly discussed Pfizer's Q4 earnings ( PFE) and the ...
JNJ's diversified pharma and MedTech growth, pipeline progress and stronger 2026 outlook give it an edge over PFE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results